簡介

本頁面提供了有關 Songjiang Ma 已知的內部交易歷史的全面分析。內部人士包括公司的高管、董事或重要投資者。一般而言,基於內幕、非公開信息進行交易是非法的。這並不意味著他們在自己的公司進行任何交易都是非法的。但是,他們必須透過Form 4向美國證券交易委員會(SEC)報告所有交易。盡管存在這些限制,學術研究表明,內部人士 - 整體而言 - 在自己公司中的投資表現往往優於市場。

平均交易盈利能力

「平均交易盈利能力」衡量了內部人士在過去三年中所有非計劃性的公開市場購買交易的平均回報率。計算過程包括檢查每筆交易,排除了作為10b5-1交易計劃的一部分的交易。然後,對每筆交易在3、6和12個月的表現進行平均,以生成該筆交易最終的表現指標。最終,將所有交易的表現指標進行平均,計算出內部人士的總體平均表現指標。列表僅包含在過去兩年中進行過至少三筆交易的內部人士。

如果內部人士的交易盈利能力顯示為"N/A",則可能是因為該內部人士在過去三年內沒有進行任何公開市場購買交易,或者他們進行的交易距離現在太近,無法計算出可靠的表現指標。

更新頻率:每日

查看收益最高的的內幕交易者列表。

報告內部持倉的公司

SEC文件顯示Songjiang Ma已報告在以下公司擁有持倉或進行了交易:

證券 職位 最新報告的持倉
US:GYRE / Gyre Therapeutics, Inc. President, Director 2,806,084
如何解讀這些圖表

以下圖表顯示了在Songjiang Ma進行的每筆公開市場非計劃交易後證券的股價表現。非計劃交易是指沒有作為10b5-1交易計劃的一部分而進行的交易。股價表現以累積百分比變化的方式繪製。例如,如果一筆內部人士交易是在2019年1月1日進行的,該圖表將顯示該證券的每日百分比變化直至當前日期。如果在此期間股價從10美元漲至15美元,則股價的累積百分比變化將為50%。從10美元漲至20美元的價格變化將為100%,而從10美元跌至5美元的價格變化將為-50%。

最終,我們將評估內部人士的交易與股價的超額回報(正向或負向)之間的相關性,以判斷內部人士是否在交易中利用內部信息獲利。如果內部人士有這樣的行為,我們預期看到(a)購買後的正回報,或者(b)賣出後的負回報。對於情況(a),購買圖表將顯示一系列向上傾斜的曲線,表示每次購買後都有正回報。對於情況(b),賣出圖表將顯示一系列向下傾斜的曲線,表示每次賣出後都有負回報。

然而,僅憑這一點還不足以得出結論。例如,如果公司的股價在多年內呈現非周期性上升,我們會預期所有購買後的圖表都呈現向上傾斜。同樣地,多年來呈現非周期性下降的股價會導致賣出後的圖表也呈現向下傾斜。這兩種情況的圖表都不能表示內部人士在進行內幕交易。

最有力的指標是在公司股價呈極度循環波動的情況下,「購買」圖表顯示正向信號,而「賣出」圖表顯示負向趨勢。這種情況強烈暗示內部人士可能根據內幕信息精確地計時進行交易,以獲得財務優勢。

歷史內部人交易

該表格顯示了由 Songjiang Ma 進行的所有內幕交易的完整列表,這些交易已向美國證券交易委員會(SEC)披露。

呈報日期 交易日期 表格 證券代碼 證券 代碼 10b5-1 股份 剩餘股份 %
變化
每股
股價
交易
金額
剩餘
金額
2025-05-29 2025-05-28 4 GYRE GYRE THERAPEUTICS, INC.
Common Stock
S - Sale X -558 2,806,084 -0.02 10.07 -5,619 28,257,266
2025-05-29 2025-05-27 4 GYRE GYRE THERAPEUTICS, INC.
Common Stock
S - Sale X -2,000 2,806,642 -0.07 10.28 -20,560 28,852,280
2025-05-27 2025-05-23 4 GYRE GYRE THERAPEUTICS, INC.
Common Stock
S - Sale X -182 2,808,642 -0.01 10.24 -1,864 28,760,494
2025-05-27 2025-05-22 4 GYRE GYRE THERAPEUTICS, INC.
Common Stock
S - Sale X -2,000 2,808,824 -0.07 10.97 -21,940 30,812,799
2025-05-22 2025-05-21 4 GYRE GYRE THERAPEUTICS, INC.
Common Stock
S - Sale X -2,000 2,810,824 -0.07 10.83 -21,660 30,441,224
2025-05-22 2025-05-20 4 GYRE GYRE THERAPEUTICS, INC.
Common Stock
S - Sale X -2,000 2,812,824 -0.07 11.25 -22,500 31,644,270
2025-05-20 2025-05-19 4 GYRE GYRE THERAPEUTICS, INC.
Common Stock
S - Sale X -2,000 2,814,824 -0.07 11.11 -22,220 31,272,695
2025-05-20 2025-05-16 4 GYRE GYRE THERAPEUTICS, INC.
Common Stock
S - Sale X -2,000 2,816,824 -0.07 11.31 -22,620 31,858,279
2025-05-16 2025-05-15 4 GYRE GYRE THERAPEUTICS, INC.
Common Stock
S - Sale X -2,000 2,818,824 -0.07 10.68 -21,360 30,105,040
2025-05-16 2025-05-14 4 GYRE GYRE THERAPEUTICS, INC.
Common Stock
S - Sale X -20 2,820,824 0.00 11.30 -226 31,875,311
2025-05-14 2025-05-13 4 GYRE GYRE THERAPEUTICS, INC.
Common Stock
S - Sale X -2,000 2,820,844 -0.07 11.37 -22,740 32,072,996
2025-05-14 2025-05-12 4 GYRE GYRE THERAPEUTICS, INC.
Common Stock
S - Sale X -2,000 2,822,844 -0.07 10.56 -21,120 29,809,233
2025-03-25 2025-03-21 4 GYRE GYRE THERAPEUTICS, INC.
Common Stock
S - Sale X -174 2,824,844 -0.01 10.00 -1,740 28,248,440
2025-03-21 2025-03-20 4 GYRE GYRE THERAPEUTICS, INC.
Common Stock
S - Sale X -2,000 2,825,018 -0.07 10.09 -20,180 28,504,432
2025-03-21 2025-03-19 4 GYRE GYRE THERAPEUTICS, INC.
Common Stock
S - Sale X -2,000 2,827,018 -0.07 10.13 -20,260 28,637,692
2025-03-19 2025-03-18 4 GYRE GYRE THERAPEUTICS, INC.
Common Stock
S - Sale X -242 2,829,018 -0.01 10.24 -2,478 28,969,144
2025-03-19 2025-03-17 4 GYRE GYRE THERAPEUTICS, INC.
Common Stock
S - Sale X -2,000 2,829,260 -0.07 12.09 -24,180 34,205,753
2025-03-17 2025-03-14 4 GYRE GYRE THERAPEUTICS, INC.
Common Stock
S - Sale X -2,000 2,831,260 -0.07 12.31 -24,620 34,852,811
2025-03-17 2025-03-13 4 GYRE GYRE THERAPEUTICS, INC.
Common Stock
S - Sale X -2,000 2,833,260 -0.07 11.80 -23,600 33,432,468
2025-03-13 2025-03-12 4 GYRE GYRE THERAPEUTICS, INC.
Common Stock
S - Sale X -2,000 2,835,260 -0.07 11.74 -23,480 33,285,952
2025-03-13 2025-03-11 4 GYRE GYRE THERAPEUTICS, INC.
Common Stock
S - Sale X -2,000 2,837,260 -0.07 11.40 -22,800 32,344,764
2025-03-11 2025-03-10 4 GYRE GYRE THERAPEUTICS, INC.
Common Stock
S - Sale X -2,000 2,839,260 -0.07 10.14 -20,280 28,790,096
2025-03-11 2025-03-07 4 GYRE GYRE THERAPEUTICS, INC.
Common Stock
S - Sale X -1,906 2,841,260 -0.07 10.13 -19,308 28,781,964
2025-03-11 2025-03-07 4 GYRE GYRE THERAPEUTICS, INC.
Common Stock
S - Sale X -41 2,843,166 0.00 12.14 -498 34,516,035
2025-03-11 2025-03-07 4 GYRE GYRE THERAPEUTICS, INC.
Common Stock
S - Sale X -53 2,843,207 0.00 13.03 -691 37,046,987
2025-03-07 2025-03-06 4 GYRE GYRE THERAPEUTICS, INC.
Common Stock
S - Sale X -2,000 2,843,260 -0.07 10.80 -21,600 30,707,208
2025-03-07 2025-03-05 4 GYRE GYRE THERAPEUTICS, INC.
Common Stock
S - Sale X -2,000 2,845,260 -0.07 10.98 -21,960 31,240,955
2025-03-05 2025-03-04 4 GYRE GYRE THERAPEUTICS, INC.
Common Stock
S - Sale X -2,000 2,847,260 -0.07 10.86 -21,720 30,921,244
2025-03-05 2025-03-03 4 GYRE GYRE THERAPEUTICS, INC.
Common Stock
S - Sale X -2,000 2,849,260 -0.07 11.23 -22,460 31,997,190
2025-03-03 2025-02-28 4 GYRE GYRE THERAPEUTICS, INC.
Common Stock
S - Sale X -2,000 2,851,260 -0.07 11.41 -22,820 32,532,877
2025-03-03 2025-02-27 4 GYRE GYRE THERAPEUTICS, INC.
Common Stock
S - Sale X -2,000 2,853,260 -0.07 11.33 -22,660 32,327,436
2025-02-27 2025-02-26 4 GYRE GYRE THERAPEUTICS, INC.
Common Stock
S - Sale X -2,000 2,855,260 -0.07 11.63 -23,260 33,206,674
2025-02-27 2025-02-25 4 GYRE GYRE THERAPEUTICS, INC.
Common Stock
S - Sale X -2,000 2,857,260 -0.07 11.37 -22,740 32,487,046
2025-02-25 2025-02-24 4 GYRE GYRE THERAPEUTICS, INC.
Common Stock
S - Sale X -187 2,859,260 -0.01 11.52 -2,154 32,938,675
2025-02-25 2025-02-24 4 GYRE GYRE THERAPEUTICS, INC.
Common Stock
S - Sale X -1,813 2,859,447 -0.06 10.60 -19,218 30,310,138
2025-02-25 2025-02-21 4 GYRE GYRE THERAPEUTICS, INC.
Common Stock
S - Sale X -182 2,861,260 -0.01 12.60 -2,293 36,051,876
2025-02-25 2025-02-21 4 GYRE GYRE THERAPEUTICS, INC.
Common Stock
S - Sale X -1,818 2,861,442 -0.06 11.84 -21,525 33,879,473
2025-02-21 2025-02-20 4 GYRE GYRE THERAPEUTICS, INC.
Common Stock
S - Sale X -2,000 2,863,260 -0.07 12.40 -24,800 35,504,424
2025-02-21 2025-02-19 4 GYRE GYRE THERAPEUTICS, INC.
Common Stock
S - Sale X -2,000 2,865,260 -0.07 12.29 -24,580 35,214,045
2025-02-19 2025-02-18 4 GYRE GYRE THERAPEUTICS, INC.
Common Stock
S - Sale X -2,000 2,867,260 -0.07 12.49 -24,980 35,812,077
2025-02-19 2025-02-14 4 GYRE GYRE THERAPEUTICS, INC.
Common Stock
S - Sale X -2,000 2,869,260 -0.07 11.94 -23,880 34,258,964
2025-02-14 2025-02-13 4 GYRE GYRE THERAPEUTICS, INC.
Common Stock
S - Sale X -2,000 2,871,260 -0.07 11.69 -23,380 33,565,029
2025-02-14 2025-02-12 4 GYRE GYRE THERAPEUTICS, INC.
Common Stock
S - Sale X -2,000 2,873,260 -0.07 11.49 -22,980 33,013,757
2025-02-12 2025-02-11 4 GYRE GYRE THERAPEUTICS, INC.
Common Stock
S - Sale X -1,878 2,875,260 -0.07 11.52 -21,635 33,122,995
2025-02-12 2025-02-10 4 GYRE GYRE THERAPEUTICS, INC.
Common Stock
S - Sale X -2,000 2,877,138 -0.07 11.90 -23,800 34,237,942
2025-02-11 2025-02-07 4 GYRE GYRE THERAPEUTICS, INC.
Common Stock
S - Sale X -2,000 2,879,158 -0.07 12.16 -24,320 35,010,561
2025-02-11 2025-02-06 4 GYRE GYRE THERAPEUTICS, INC.
Common Stock
S - Sale X -2,000 2,881,138 -0.07 12.85 -25,700 37,022,623
2025-02-06 2025-02-05 4 GYRE GYRE THERAPEUTICS, INC.
Common Stock
S - Sale X -20 2,883,138 0.00 12.84 -257 37,019,492
2025-02-06 2025-02-05 4 GYRE GYRE THERAPEUTICS, INC.
Common Stock
S - Sale X -1,980 2,883,158 -0.07 12.39 -24,532 35,722,328
2025-02-06 2025-02-04 4 GYRE GYRE THERAPEUTICS, INC.
Common Stock
S - Sale X -2,000 2,885,138 -0.07 11.62 -23,240 33,525,304
2025-02-04 2025-02-03 4 GYRE GYRE THERAPEUTICS, INC.
Common Stock
S - Sale X -2,000 2,887,138 -0.07 11.47 -22,940 33,115,473
2025-02-04 2025-01-31 4 GYRE GYRE THERAPEUTICS, INC.
Common Stock
S - Sale X -2,000 2,889,138 -0.07 11.51 -23,020 33,253,978
2025-01-31 2025-01-30 4 GYRE GYRE THERAPEUTICS, INC.
Common Stock
S - Sale X -2,000 2,891,138 -0.07 11.37 -22,740 32,872,239
2025-01-31 2025-01-29 4 GYRE GYRE THERAPEUTICS, INC.
Common Stock
S - Sale X -2,000 2,893,138 -0.07 11.43 -22,860 33,068,567
2025-01-29 2025-01-28 4 GYRE GYRE THERAPEUTICS, INC.
Common Stock
S - Sale X -2,000 2,895,138 -0.07 11.51 -23,020 33,323,038
2025-01-29 2025-01-27 4 GYRE GYRE THERAPEUTICS, INC.
Common Stock
S - Sale X -2,000 2,897,138 -0.07 11.18 -22,360 32,390,003
2025-01-27 2025-01-24 4 GYRE GYRE THERAPEUTICS, INC.
Common Stock
S - Sale X -2,000 2,899,138 -0.07 10.89 -21,780 31,571,613
2025-01-27 2025-01-23 4 GYRE GYRE THERAPEUTICS, INC.
Common Stock
S - Sale X -2,000 2,901,138 -0.07 10.49 -20,980 30,432,938
2025-01-24 2025-01-22 4 GYRE GYRE THERAPEUTICS, INC.
Common Stock
S - Sale X -2,000 2,903,138 -0.07 10.63 -21,260 30,860,357
2025-01-24 2025-01-21 4 GYRE GYRE THERAPEUTICS, INC.
Common Stock
S - Sale X -2,000 2,905,138 -0.07 10.85 -21,700 31,520,747
2025-01-21 2025-01-17 4 GYRE GYRE THERAPEUTICS, INC.
Common Stock
S - Sale X -2,000 2,907,138 -0.07 10.72 -21,440 31,164,519
2025-01-21 2025-01-16 4 GYRE GYRE THERAPEUTICS, INC.
Common Stock
S - Sale X -2,000 2,909,138 -0.07 10.71 -21,420 31,156,868
2025-01-16 2025-01-15 4 GYRE GYRE THERAPEUTICS, INC.
Common Stock
S - Sale X -2,000 2,911,138 -0.07 10.85 -21,700 31,585,847
2025-01-16 2025-01-14 4 GYRE GYRE THERAPEUTICS, INC.
Common Stock
S - Sale X -2,000 2,913,138 -0.07 10.39 -20,780 30,267,504
2025-01-14 2025-01-13 4 GYRE GYRE THERAPEUTICS, INC.
Common Stock
S - Sale X -56 2,915,138 0.00 10.10 -566 29,442,894
2025-01-14 2025-01-10 4 GYRE GYRE THERAPEUTICS, INC.
Common Stock
S - Sale X -1,057 2,915,194 -0.04 10.02 -10,591 29,210,244
2025-01-10 2025-01-03 4/A GYRE GYRE THERAPEUTICS, INC.
Common Stock
S - Sale -833 2,918,467 -0.03 11.85 -9,871 34,583,834
2025-01-08 2025-01-07 4 GYRE GYRE THERAPEUTICS, INC.
Common Stock
S - Sale X -1,275 2,916,251 -0.04 10.02 -12,776 29,220,835
2025-01-08 2025-01-06 4 GYRE GYRE THERAPEUTICS, INC.
Common Stock
S - Sale X -941 2,917,526 -0.03 10.16 -9,561 29,642,064
2025-01-06 2025-01-03 4 GYRE GYRE THERAPEUTICS, INC.
Common Stock
S - Sale X -1,167 2,919,300 -0.04 11.03 -12,872 32,199,879
2025-01-06 2025-01-02 4 GYRE GYRE THERAPEUTICS, INC.
Common Stock
S - Sale X -2,000 2,920,467 -0.07 12.40 -24,800 36,213,791
2025-01-06 2024-01-03 4 GYRE GYRE THERAPEUTICS, INC.
Common Stock
S - Sale X -833 2,918,467 -0.03 11.85 -9,871 34,583,834
2025-01-02 2024-12-31 4 GYRE GYRE THERAPEUTICS, INC.
Common Stock
S - Sale X -2,000 2,922,467 -0.07 12.30 -24,600 35,946,344
2025-01-02 2024-12-30 4 GYRE GYRE THERAPEUTICS, INC.
Common Stock
S - Sale X -2,000 2,924,467 -0.07 12.50 -25,000 36,555,838
2024-12-30 2024-12-27 4 GYRE GYRE THERAPEUTICS, INC.
Common Stock
S - Sale X -2,000 2,926,467 -0.07 12.58 -25,160 36,814,955
2024-12-30 2024-12-26 4 GYRE GYRE THERAPEUTICS, INC.
Common Stock
S - Sale X -356 2,928,467 -0.01 13.05 -4,646 38,216,494
2024-12-30 2024-12-26 4 GYRE GYRE THERAPEUTICS, INC.
Common Stock
S - Sale X -1,644 2,928,823 -0.06 12.62 -20,747 36,961,746
2024-12-26 2024-12-24 4 GYRE GYRE THERAPEUTICS, INC.
Common Stock
S - Sale X -2,000 2,930,467 -0.07 11.93 -23,860 34,960,471
2024-12-26 2024-12-23 4 GYRE GYRE THERAPEUTICS, INC.
Common Stock
S - Sale X -296 2,932,467 -0.01 12.44 -3,682 36,479,889
2024-12-26 2024-12-23 4 GYRE GYRE THERAPEUTICS, INC.
Common Stock
S - Sale X -1,704 2,932,763 -0.06 12.24 -20,857 35,897,019
2024-12-23 2024-12-20 4 GYRE GYRE THERAPEUTICS, INC.
Common Stock
S - Sale X -2,000 2,934,467 -0.07 10.90 -21,800 31,985,690
2024-12-23 2024-12-19 4 GYRE GYRE THERAPEUTICS, INC.
Common Stock
S - Sale X -2,000 2,936,467 -0.07 10.82 -21,640 31,772,573
2024-12-19 2024-12-18 4 GYRE GYRE THERAPEUTICS, INC.
Common Stock
S - Sale X -429 2,938,467 -0.01 12.11 -5,195 35,584,835
2024-12-19 2024-12-18 4 GYRE GYRE THERAPEUTICS, INC.
Common Stock
S - Sale X -1,571 2,938,896 -0.05 11.17 -17,548 32,827,468
2024-12-19 2024-12-17 4 GYRE GYRE THERAPEUTICS, INC.
Common Stock
S - Sale X -788 2,940,467 -0.03 11.23 -8,849 33,021,444
2024-12-19 2024-12-17 4 GYRE GYRE THERAPEUTICS, INC.
Common Stock
S - Sale X -1,212 2,941,255 -0.04 10.94 -13,259 32,177,330
2023-11-22 3/A GYRE GYRE THERAPEUTICS, INC.
Common Stock
2,942,467
P
非衍生或衍生證券的公開市場或私下買入
S
非衍生或衍生證券的公開市場或私下賣出
A
公司向內部人員授予、獎勵或以其他方式獲取證券(例如股票期權)
C
衍生工具轉換
D
將證券賣出或轉讓回公司
F
使用從公司收到的證券的一部分來支付行使價或稅務負擔。
G
內部人士贈送或接收他人贈送公司股票
K
股權掉期和類似的避險交易
M
行使或轉換從公司獲得的衍生證券(例如期權)
V
內部人士透過Form 4自願報告的一筆交易
J
其他(附有交易描述的腳註)